Institution-wide online subscription to cancer research and drug development content

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700067A
Awardee
Awarding agency
Obligated
$48,000

Award facts

Opportunity
Contract value 100% obligated
$48,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
519130 Internet Publishing and Broadcasting and Web Search Portals
PSC
7610 Books And Pamphlets
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20016, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Cancer Letter Inc. for institution-wide online subscription to cancer research and drug development content, valued at $48,000, with an award date of September 21, 2017. The order is set-aside for total small business. Performance occurs in Washington, DC, with an ultimate completion date of September 20, 2018. The subscription provides access to the vendor's weekly online periodical covering cancer research, drug development, and health policy. Pricing is firm fixed price.

Quick answers

Who was awarded contract HHSN261201700067A?

HHSN261201700067A was awarded to Cancer Letter Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2017.

How much is contract HHSN261201700067A worth?

The government has obligated $48,000 on HHSN261201700067A.

Was contract HHSN261201700067A competed?

The extent of competition for HHSN261201700067A was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login